Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07462546
NA

Transcranial Doppler for Internal Carotid Artery Stenting (TCD-ICAS)

Sponsor: General Hospital of Shenyang Military Region

View on ClinicalTrials.gov

Summary

Carotid artery stenting (CAS) prevents stroke but carries risks of perioperative cerebral embolism. Transcranial Doppler (TCD) ultrasound can detect microemboli during CAS and may offer therapeutic benefits through ultrasound-enhanced thrombolysis. Trials like SONOBUSTER and SONOBIRDIE suggest TCD reduces new brain infarctions during carotid procedures. The TCD-ICAS trial will investigate whether TCD application during and after CAS reduces perioperative cerebral emboli and improves outcomes.

Official title: Transcranial Doppler for Internal Carotid Artery Stenting (TCD-ICAS): A Prospective, Randomized Controlled, Blind Endpoint, Single-Center Study

Key Details

Gender

All

Age Range

40 Years - Any

Study Type

INTERVENTIONAL

Enrollment

232

Start Date

2026-03-24

Completion Date

2026-11-30

Last Updated

2026-03-25

Healthy Volunteers

No

Conditions

Interventions

DEVICE

Transcranial Doppler

TCD treatment (1.6 MHz, 0.274 MPa) from femoral artery puncture until 30-60 minutes after procedure completion

Locations (1)

Department of Neurology, General Hospital of Northern Theater Command

Shenyang, China